The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bhavnagri Veer since 2020.
This trader's CIK number is 1808980.
At the time of last reporting, Bhavnagri Veer was the General Counsel of Allogene Therapeutics, Inc.. (stock ticker symbol ALLO).
Also see all insider trading activities at Allogene Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ALLO | 0 | $0 | 6,000 | $41,670 | 0 | $0 |
| 2022 | ALLO | 0 | $0 | 8,849 | $67,960 | 0 | $0 |
| 2021 | ALLO | 0 | $0 | 56,623 | $1,710,177 | 50,000 | $113,500 |
| 2020 | ALLO | 0 | $0 | 116,553 | $4,269,226 | 161,500 | $366,605 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-13 | ALLO | Sale | 3,000 | 6.85 | 20,550 |
| 2023-01-17 | ALLO | Sale | 3,000 | 7.04 | 21,120 |
| 2022-03-15 | ALLO | Sale | 8,849 | 7.68 | 67,960 |
| 2021-09-15 | ALLO | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-09-15 | ALLO | Sale | 5,000 | 24.77 | 123,844 |
| 2021-08-16 | ALLO | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-08-16 | ALLO | Sale | 5,000 | 21.00 | 104,995 |
| 2021-07-15 | ALLO | Sale | 5,000 | 21.55 | 107,754 |
| 2021-07-15 | ALLO | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-06-15 | ALLO | Sale | 5,000 | 25.32 | 126,600 |
| 2021-06-15 | ALLO | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-05-18 | ALLO | Sale | 5,000 | 30.00 | 150,000 |
| 2021-05-18 | ALLO | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-05-17 | ALLO | Sale | 5,000 | 28.30 | 141,475 |
| 2021-05-17 | ALLO | Option Ex | 5,000 | 2.27 | 11,350 |
| 2021-04-15 | ALLO | Option Ex | 10,000 | 2.27 | 22,700 |
| 2021-04-15 | ALLO | Sale | 10,000 | 32.33 | 323,270 |
| 2021-03-15 | ALLO | Option Ex | 10,000 | 2.27 | 22,700 |
| 2021-03-15 | ALLO | Sale | 16,623 | 38.03 | 632,239 |
| 2020-12-17 | ALLO | Option Ex | 51,500 | 2.27 | 116,905 |
| 2020-10-06 | ALLO | Option Ex | 10,000 | 2.27 | 22,700 |
| 2020-10-06 | ALLO | Sale | 10,000 | 40.00 | 400,000 |
| 2020-10-01 | ALLO | Option Ex | 25,000 | 2.27 | 56,750 |
| 2020-10-01 | ALLO | Sale | 25,000 | 36.99 | 924,649 |
| 2020-09-01 | ALLO | Sale | 25,000 | 35.62 | 890,499 |
| 2020-09-01 | ALLO | Option Ex | 25,000 | 2.27 | 56,750 |
| 2020-09-01 | ALLO | Sale | 25,000 | 35.62 | 890,499 |
| 2020-09-01 | ALLO | Option Ex | 25,000 | 2.27 | 56,750 |
| 2020-08-03 | ALLO | Sale | 31,553 | 36.88 | 1,163,579 |
| 2020-08-03 | ALLO | Option Ex | 25,000 | 2.27 | 56,750 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bhavnagri Veer (General Counsel of Allogene Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.